Taoyuan, Taiwan

Chih-Wei Tseng

This inventor holds 1 USPTO granted patent. Top assignee: Sci Pharmtech Inc.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chih-Wei Tseng. Retrieved from https://idiyas.com/inventor/chih-wei-tseng-7yiysiy5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chih-Wei Tseng: Innovator in Pharmaceutical Chemistry

Introduction

Chih-Wei Tseng is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for therapeutic use. His innovative work has led to the creation of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Chih-Wei Tseng holds a patent for a compound and method for the preparation of lisdexamfetamine. This patent includes a compound represented by Formula (VI) for preparing lisdexamfetamine or a salt thereof. The method involves performing reduction and debenzylation of the compound by hydrogenation, highlighting his technical proficiency in chemical processes.

Career Highlights

Tseng is currently associated with Sci Pharmtech Inc., where he applies his knowledge and skills to further research and development in the pharmaceutical industry. His work at the company emphasizes the importance of innovation in creating effective medications.

Conclusion

Chih-Wei Tseng's contributions to pharmaceutical chemistry through his patent for lisdexamfetamine exemplify his role as an inventor dedicated to improving healthcare solutions. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…